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ABSTRACT 
 
Post-translational modification of histones play essential roles in the 
transcriptional regulation of genes in eukaryotes.  Methylation on basic residues of 
histones is regulated by histone methyltransferases and histone demethylases, and 
misregulation of these enzymes has been linked to a range of diseases such as cancer.  
Histone lysine demethylase 2 (KDM2) family proteins have been shown to either 
promote or suppress tumorigenesis in different human malignancies.  However, the roles 
and regulation of KDM2 in development are poorly understood, and the exact roles of 
KDM2 in regulating demethylation remain controversial.  Since KDM2 proteins are 
highly conserved in multicellular animals, we analyzed the KDM2 ortholog in 
Drosophila.  We have observed that dKDM2 is a nuclear protein and its level fluctuates 
during fly development.  We generated three deficiency lines that disrupt the dKdm2 
locus, and together with 10 transposon insertion lines within the dKdm2 locus, we 
characterized the developmental defects of these alleles.  The alleles of dKdm2 define 
three phenotypic classes, and the intragenic complementation observed among these 
alleles and our subsequent analyses suggest that dKDM2 is not required for viability.  In 
addition, loss of dKDM2 appears to have rather weak effects on histone H3 lysine 36 
and 4 methylation (H3K36me and H3K4me) in the third instar wandering larvae, and we 
observed no effect on methylation of H3K9me2, H3K27me2 and H3K27me3 in dKdm2 
mutants.  Taken together, these genetic, molecular and biochemical analyses suggest that 
 iii 
 
dKDM2 is not required for viability of flies, indicating that dKdm2 is likely redundant 
with other histone lysine demethylases in regulating normal development in Drosophila. 
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1. INTRODUCTION*  
 
In eukaryotes, DNA wraps around core histones to form nucleosomes, which are 
compacted into high-order structures of chromosome in a highly dynamic and cell-cycle 
dependent manner.  Covalent modifications of histone N-terminal tails, such as 
methylation, acetylation, and phosphorylation, correlate with chromatin structure and 
seem to influence multiple steps of transcription (Bannister and Kouzarides, 2011; 
Zentner and Henikoff, 2013).  Accumulating evidences in recent years revealed that 
misregulation of these enzymes are linked to a range of diseases such as cancer (Chi et 
al., 2010; Greer and Shi, 2012; Timp and Feinberg, 2013). 
Of a variety of these post-translational modifications on histone tails, methylation 
of histone H3 Lysine 36 (H3K36me) shows a strong correlation with transcription 
elongation (Joshi and Struhl, 2005; Li et al., 2007; Smolle and Workman, 2013).  
Histone methyltransferase Set2 in yeast and nuclear receptor SET domain-containing 1 
(NSD1) in humans control the methylation of H3K36 forming mono-, di- or tri-
methylation on K36 (abbreviated as H3K36me1, H3K36me2 or H3K36me3, 
respectively) (Wagner and Carpenter, 2012).  Conversely, the histone demethylases such 
as KDM2, KDM4 and KDM8 have been shown to specifically demethylate H3K36me 
(Crona et al., 2013; Hsia et al., 2010; Jones et al., 2010; Lin et al., 2012; Tsukada et al., 
                                                
* Reprinted from Mechanisms of Development, 133, Yani Zheng, Fu-Ning Hsu, Wu Xu, Xiao-Jun Xie, 
Xinjie Ren, Xinsheng Gao, Jian-Quan Ni, Jun-Yuan Ji, A developmental genetic analysis of the lysine 
demethylase KDM2 mutations in Drosophila melanogaster, 36-53, Copyright (2014), with permission 
from Elsevier. 
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2006).  There are two KDM2 paralogs in vertebrates: KDM2A (also known as FBXL11, 
JHDM1A, and Ndy2) and KDM2B (also known as FBXL10, JHDM1B, and Ndy1) 
(Allis et al., 2007; Cloos et al., 2008; Tsukada et al., 2006).  Both proteins contain 
several conserved domains including the JmjC domain, a CXXC-type zinc finger, a PHD 
finger (Plant Homeo Domain), an F-box domain and several leucine-rich repeats 
(LRRs), and the JmjC domain harbors the demethylase activity (Blackledge et al., 2010; 
Cloos et al., 2008; Frescas et al., 2007; Lohse et al., 2011; Tsukada et al., 2006).   
The importance of KDM2 is highlighted by studies that linking KDM2 to cancer 
development in recent years.  However, the role of KDM2 seems to be either tumor 
suppressive or oncogenic, depending on specific types of cancers.  On the one hand, 
KDM2 has been reported to function as a putative proto-oncogene in certain types of 
cancers.  For example, the expression of hKdm2b gene is up-regulated in human 
leukemic stem cells and ectopic expression of hKDM2B is sufficient to transform 
hematopoietic progenitors (He et al., 2011).  In addition, hKDM2B is required for 
Hox9a/Meis1-induced leukemic transformation, and hKDM2B regulates leukemic cell 
proliferation by directly repressing the expression of the tumor suppressor Ink4b (He et 
al., 2011).  Similarly, depletion of KDM2B in primary mouse embryonic fibroblasts 
inhibits cell proliferation and induces senescence by direct depression of the Ink4b locus 
(He et al., 2008).  Moreover, it was reported that KDM2B inhibits replicative or Ras-
induced senescence by directly repressing the Ink4a/Arf locus in cultured mouse 
embryonic fibroblasts (Pfau et al., 2008; Tzatsos et al., 2009).  KDM2B can also repress 
the expression of c-Jun (Koyama-Nasu et al., 2007).  Furthermore, KDM2B is found to 
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be markedly overexpressed in pancreatic cancer cell lines and patient specimens, and its 
levels positively correlated to the severity of the disease (Tzatsos et al., 2013).  
Interestingly, mouse KDM2B is shown to be required for H2AK119 monoubiquitination 
and regulates mouse embryonic stem cell differentiation (Wu et al., 2013).  Together 
with investigations on other KDMs, these studies have linked histone lysine 
demethylases to a variety of cancers, thus these enzymes have been considered as strong 
candidates for development of specific inhibitors in cancer therapy (Lohse et al., 2011; 
Rotili and Mai, 2011).   
On the other hand, however, KDM2 has been reported to have tumor suppressive 
functions in other types of cancers.  For instance, KDM2B inhibits cell growth and 
proliferation in HeLa cells (Frescas et al., 2007; Koyama-Nasu et al., 2007).  Expression 
of KDM2B is significantly decreased in many primary brain tumors, and the decrease of 
KDM2B expression correlates with tumor grade (Frescas et al., 2007).  In addition, 
retroviral disruption of KDM2B gene causes lymphoma in BLM-deficient mice (Suzuki 
et al., 2006).  Furthermore, KDM2B binds to ribosomal DNA repeats and represses 
rRNA genes in the nucleolus (Frescas et al., 2007).  Consistent with this, hKDM2A is 
involved in repressing rDNA transcription in a demethylase activity-dependent manner 
in human breast cancer cells in response to starvation of glucose and serum (Tanaka et 
al., 2010).  Compared to KDM2B, less is known about tumorigenic roles of KDM2A.  It 
has been shown that KDM2A suppresses the growth of colon cancer cells by directly 
demethylating p65 (RelA) thereby inhibiting NF-κB activities (Lu et al., 2010).  Taken 
together, these observations suggest a tumor suppressive role of KDM2.  Considering 
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the aforementioned oncogenic roles of KDM2 proteins, it thus appears that the role of 
KDM2 in cancer progression is dependent on specific biological contexts, which is 
consistent with the view that histone modification enzymes play context-specific roles in 
regulating tumorigenesis (Sarris et al., 2013).   
Despite these studies, the role of KDM2s during development in the whole 
organisms remains poorly understood (Nottke et al., 2009).  Simple model organisms 
such as Drosophila provide a plethora of genetic tools that can facilitate the studies of 
the evolutionarily conserved regulatory mechanisms in vivo.  The Drosophila KDM2 
(dKDM2) is the single homolog of the mammalian KDM2A and KDM2B (Panel A of 
the figure on Page 14) (Dui et al., 2012; Jin et al., 2004; Kavi and Birchler, 2009; 
Lagarou et al., 2008).  Biochemical purification for dRING-associated proteins coupled 
with mass spectrometric analysis led to the identification of dKDM2 as a component of 
dRING-associated factors complex (dRAF), a Polycomb group (PcG) silencing complex 
composed of dRING, Posterior Sex Comb (PSC) and dKDM2 (Lagarou et al., 2008).  
Depletion of dKDM2 in cultured S2 cells significantly increased levels of H3K36me2 
and caused loss of H2A ubiquitination, but did not affect the levels of H3K36me1, 
H3K36me3 and H3K4me3 (Lagarou et al., 2008).  These observations demonstrate that 
dKDM2 plays a key role in dRAF complex by mediating both demethylation of 
H3K36me2 and ubiquitination of H2A (Lagarou et al., 2008).  Similar approach using 
murine erythroleukemia cells led to the identification of KDM2B as a component of the 
KDM2B-RING1B complex, which includes RING1B, Bcl6 corepressor (BCoR), Skp1, 
and a few other proteins that are involved in regulating H2A ubiquitination (Sanchez et 
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al., 2007).  Depletion of KDM2B was also shown to significantly reduce H2A 
ubiquitination in mouse embryonic stem cells (Wu et al., 2013).  However, knocking 
down dKDM2 in vivo using actin5C-Gal4 to drive the expression of dKdm2-dsRNA in 
the third instar larvae did not reveal any effects of dKDM2 depletion on the levels of 
H3K36me2, H3K9me2, and H3K4me2 assayed by Western blot and 
immunofluorescence staining; instead, a strong increase of H3K4me3 was observed, 
suggesting that dKDM2 specifically demethylates H3K4me3 in vivo (Kavi and Birchler, 
2009).  In addition, depletion of dKDM2 in salivary glands resulted in multiple nucleoli 
(Kavi and Birchler, 2009).  These observations are consistent to the role of KDM2B in 
repressing rRNA gene expression by demethylating H3K4me3 in nucleolus (Frescas et 
al., 2007).  It is still unclear why dKDM2 displayed different functions in these two 
reports.  Perhaps, dKDM2 can serve as a component in multiple protein complexes that 
regulate different target genes, thereby enabling it to demethylate H3K4me3, or 
H3K36me2, or both, in a context-specific manner.   
To clarify the functions of dKDM2 in vivo, it is essential to analyze the loss of 
dKdm2 mutants during development.  No studies performed to date, however, have 
characterized the phenotypes of dKdm2 mutants, because no null alleles of dKdm2 are 
available and several dKdm2 alleles caused by transposon insertions remain 
uncharacterized.  In this study, we analyzed the role of dKDM2 in Drosophila 
development by charactering the developmental defects of multiple dKdm2 alleles and 
their effects on histone modifications in vivo.  Specifically, we have generated three 
deficiency lines that remove the dKdm2 locus, and then characterized these three 
 6 
 
deficiency lines together with 10 transposon insertion lines within the dKdm2 locus.  We 
observed that dKDM2 is a nuclear protein and is expressed throughout development 
with relatively low expression during the first and second larval stages.  In addition, the 
effects of loss of dKDM2 on histone lysine 4 and lysine 36 methylation seem to be 
rather mild during the third instar wandering stage.  Our genetic and biochemical 
analyses suggest that dKDM2 is not required for viability, indicating that the role of 
dKDM2 may be redundant with other histone demethylases.   
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2. MATERIALS & METHODS*  
 
2.1 Phylogenetic analysis 
The amino acid sequences of KDM2 proteins from different species were 
downloaded from the National Center for Biotechnology Information (NCBI) database 
and imported to MEGA5 (Tamura et al., 2011).  The pairwise algorithm and the 
Neighbor-Joining algorithm built in MEGA 5 were used to construct the phylogenetic 
tree.  The NCBI Reference Sequence numbers for these KMD2 proteins are listed in the 
figure on Page 16, and the protein-protein BLAST (BLASTp) (Altschul et al., 1997) was 
used to search for the putative conserved domains for each KDM2 proteins (see the 
figure on Page 16). 
 
2.2 Fly Strains 
Drosophila strains and crosses were maintained on standard cornmeal-yeast agar 
food at 25°C.  We used w1118 flies as the control.  The following dKdm2 alleles were 
obtained from the Bloomington Drosophila Stock Center: dKdm2DG12810 (genotype: 
P[wHy]dKdm2DG12810), dKdm2F11.1 (w*; P[ID.GAL4DBD]dKdm2F11.1), dKdm2KG04325 (y1 
w67c23; P[SUPor-P]dKdm2KG04325 ry506), dKdm2EY01336 (y1 w67c23; 
P[EPgy2]dKdm2EY01336), dKdm2EP3093 (w1118; P[EP]dKdm2EP3093/TM6B, Tb1).  In 
                                                
* Reprinted from Mechanisms of Development, 133, Yani Zheng, Fu-Ning Hsu, Wu Xu, Xiao-Jun Xie, 
Xinjie Ren, Xinsheng Gao, Jian-Quan Ni, Jun-Yuan Ji, A developmental genetic analysis of the lysine 
demethylase KDM2 mutations in Drosophila melanogaster, 36-53, Copyright (2014), with permission 
from Elsevier. 
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addition, several P-element and PiggyBac insertion lines that were generated by 
Exelixis, including d06162 (P[XP]dKdm2d06162), f02828 (PBac[WH]dKdm2f02828), 
d06730 (P[XP]dKdm2d06730), and e01422 (PBac[RB]Adae01422), were obtained from the 
Exelixis Collection at the Harvard Medical School (https://drosophila.med.harvard.edu/) 
 
2.3 PCR analysis of the deletion lines 
To prepare genomic DNAs (gDNAs) from the homozygous Df(3R)J15 (first 
instar and the third instar larvae), Df(3R)J16 and Df(3R)J18 (third instar at the 
wandering stage) mutant larvae, we used the methods as described previously (Parks et 
al., 2004).  First, we used the genomic PCR approach (Panel A of the figure on Page 22) 
with Taq polymerase (Invitrogen) for 35 elongation (5.0 min) and annealing (at 55°C) 
cycles.  The following primers were used for Panel B of the figure on Page 22: 1F: 5’-
CGAATATACGTGGAGCGTGA; 2R: 5’-TGGGGGTACTTGAAAATTCG; 3F: 5’-
CGGTTGTAGCCGTTAGGAAA; and 4R: 5’-CTCGTGCACAAATGCAAACT.  In 
addition, we used the hybrid PCR approach (Panel D of the figure on Page 22) to 
validate Df(3R)J15 and Df(3R)J15# lines using primers F: 5’-
ATGATTCGCAGTGGAAGGCT and R: 5’- GACGCATGATTATCTTTTACGTGAC; 
for Df(3R)J16 and Df(3R)J18 lines, we used these primers: F: 5’-
ATGATTCGCAGTGGAAGGCT and R: 5’-TGCATTTGCCTTTCGCCTTAT.  The 
w1118 line was used as the control for these reactions. 
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2.4 Validation of the transposon insertion lines by PCR 
Similarly, the insertion alleles of dKdm2 were also validated by PCR using the 
gDNA of each allele.  We used Taq polymerase (Invitrogen) with 3.5 min as elongation 
time to ensure all the fragments (<2.7kb) can be amplified and the annealing temperature 
was 55°C.  The primers used for the positive control reaction are: “dKdm2-34F” 5’-
AATCTTCAAAGTTCGCGCAGG and “dKdm2-56R” (5’-
GCAATGTATTTCCATCCGCG-3’), which generate a 2682-bp product (See the figure 
on Page 25).  The primers for specific alleles are listed below: for dKdm2d00170 allele (F: 
5’- ATAGGTTGTGGAAGCGAACG; R: 5’- ACGCCCACGTATCACTTTTC), 
dKdm2DG12810 allele (F: 5’-GCGGAAAGGCATAATTGAAA; R: 5’-
TCGCCTTCACTTTCTCCAGT), dKdm2EY01336 allele (F: 5’- 
GCGGCCAAAATAAACTCAAA; R: 5’-GCCTTCACTTTCTCCAGTCG), dKdm2F11.1 
allele (F: 5’-GCGGCCAAAATAAACTCAAA; R: 5’-GCCTTCACTTTCTCCAGTCG), 
dKdm2KG04325 allele (F: 5’- ATAGGTTGTGGAAGCGAACG; R: 5’-
ACGCCCACGTATCACTTTTC), dKdm2EP3093 allele (using the gDNA from 
dKdm2EP3093/TM6B as the template, the following two set of primers were used: F1: 5’- 
TGGAATCGACCTTTCTTTGC; R1: 5’-CGGGATATGGAGCAGTTGTT; F2: 5’-
TGGAATCGACCTTTCTTTGC; R2: 5’-CGGGATATGGAGCAGTTGTT).  The same 
primers were used to verify the background cleaned-up dKdm2d00170#, and dKdm2EP3093# 
alleles. The primers used to verify the dKdm2f02828# allele are F: 5’-
GCGGCCAAAATAAACTCAAA  and R: 5’-GCCTTCACTTTCTCCAGTCG.  Taq 
DNA polymerase (Invitrogen) was used in the PCR reactions, the annealing temperature 
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was 55°C, and the elongation time was 3.5 min to ensure all the fragments (<2.7kb) can 
be amplified.  
 
2.5 qRT-PCR analysis 
We performed qRT-PCR analyses using the StepOnePlus Real-Time PCR 
System (Applied Biosystems) as previously described (Zhao et al., 2012).  The qPCR 
primers were designed using Primer Express software (Applied Biosystems), and the 
following primers were used to detect the mRNA levels of dKdm2 and three of its 
neighboring genes (Mst85C, beag and ada) during the larval stage: dKdm2-23 (F: 5’-
GTCCAAATGCAAAAGGCGTG; R: 5’- AGATTCGAGCTTCTCGGCAAC), dKdm2-
34 (F: 5’- AATCTTCAAAGTTCGCGCAGG; R: 5’- 
CGCTTTGTCCCGGAATAACAG), dKdm2-56 (F: 5’- 
CCGCTCTGGCAAAAACTATGAC; R: 5’- GCAATGTATTTCCATCCGCG), Mst85C 
(F: 5’- GCATAAGCGAAAATCCGAGCA; R: 5’- 
TCTTCGGATCCAGCGATAGACC), beag (F: 5’- GTCCTTTGGCAGTTTTCGCTT; 
R: 5’- ACTACATGAGCACGAAGGAGGC), ada (F: 5’- 
GCGATTCGAGATTTCGCTGA; R: 5’-TCACGATCTGCAGGTAGTCCCT), and rp49 
(F: 5’- ACAGGCCCAAGATCGTGAAGA; R: 5’- CGCACTCTGTTGTCGATACCCT) 
was used as the reference gene.  Since hKDM2B was reported to repress rRNA gene 
expression and knocking down of dKDM2 in salivary glands leads to multiple nucleoli 
(Frescas et al., 2007; Kavi and Birchler, 2009), we verified the levels of Rp49 gene using 
GAPDH and found no effect of dKdm2 on the levels of Rp49 
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The quality of the qRT-PCR primers was verified by examining the melting curve and 
electrophoresis in 1.2% agarose gel.  In all cases, three independent biological repeats of 
each genotype were assays.    
 
2.6 Generation of GST-dKDM2 fragments 
To generate the GST-fused dKDM2 (AA1~220) protein, we used the Gateway 
Technology (Invitrogen).  Briefly, AA1~220 was amplified using Phusion High-Fidelity 
DNA Polymerases (F-530S; New England Biolabs) and following primers:  F: 5’-
CACCATGTCCACCGCCGTTGAAACG and R: 5’-
TCATAGCAGATTGGTGCCCTCCCG.  The annealing temperature for the PCR 
reaction was 60°C and elongation time was 2.0 min for 35 cycles.  The PCR product was 
purified, then ligated into the pENTR/D-TOPO vector using the pENTR/D-TOPO 
Cloning kit (K240020, Invitrogen), and subsequently verified by sequencing.  The 
pDEST15 was used as the destination vector and the attL × attR reaction was mediated 
by LR Clonase II enzyme mix (11791-020, Invitrogen) following the manufacturer’s 
protocols.  The GST-fused dKDM2 (AA1~220; see the figure on Page 20) was 
expression of pDEST15-dKDM2 (AA1~220) in E. coli (Rosetta) cells.  The GST-fusion 
protein was purified and stained with the Commassie blue following the standard 
biochemical methods.  
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2.7 Western blot analysis and antibodies 
Polyclonal rabbit antiserum against dKDM2 was generated using peptide 
AA37~56 (KGVQRRQLRERKQRKKYLEE) as the antigen.  The rabbit immunizations 
were performed by Pierce Biotechnology, Thermo Scientific (Rockford, IL).  The 
antiserum was purified using GST-fused dKDM2 (AA1~220; see the figure on Page 20) 
using the protocol as described previously (Tang, 1993).  Cytoplasmic, nuclear soluble, 
and nuclear insoluble fractions of protein extractions were prepared following the 
protocol as described (Lin et al., 2012).  We found that dKDM2 is only present in the 
nuclear soluble fraction (see the figure on Page 19), thus the levels of dKDM2 in this 
fraction were further analyzed in all of the subsequent experiments.  
To analyze histone modification, we prepared histones from the third instar 
larvae at the wandering stage or cultured Drosophila S2-DRSC cells using the EpiSeeker 
Histone Extraction Kit (ab113476 from Abcam, Cambridge, UK).  Briefly, 15 larvae per 
sample, three samples per genotype, were grinded in 300 µl 1X Pre-lysis Buffer, 
centrifuge at 1,000 rpm at 4° for 1.0 min and the pellet was re-suspended in 100 µl of 
Lysis Buffer.  The rest of the steps were performed according the manufacture 
instructions.  The experiments were repeated several times and the representative results 
are presented.  Antibodies against histone modifications include: anti-histone H3 
(9717S; 1:2000), anti-H3K4me2 (9725; 1:2000) were from Cell Signaling Technology 
(Danvers, MA); while anti-H3K4me1 (ab8895; 1:2000), anti-H3K4me3 (ab8580; 
1:2000), anti-H3K9me2 (ab1220; 1:2000), anti-H3K27me2 (ab24684; 1:2000), anti-
H3K36me1 (ab9048; 1:2000), anti-H3K36me2 (ab9049; 1:2000), and anti-H3K36me3 
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(ab9050; 1:2000) were purchased from Abcam, and anti-H3K27me3 (07-447; 1:2000) 
was from Millipore (Temecular, CA).  The Actin pan monoclonal antibody (MA5-
11869, 1:4000) was purchased from Thermo Scientific (Waltham, MA).  
 
2.8 Generation of dKdm2-dsRNAs and depletion of dKDM2 in S2-DRSC cells 
To avoid potential off-target effects, the dsRNAs targeting dKdm2 and white 
were designed using the online program developed by Dr. Norbert Perrimon’s lab 
(http://www.flyrnai.org/cgi-bin/RNAi_find_primers.pl).  The dsRNAs were generated 
following the same protocols as described previously (Dimova et al., 2003; Ji et al., 
2012).  The following primer sets were used to generate dsRNAs to dKdm2-1 (F: 5’- 
GTTCTCTCTGGCAAACAGGC; R: 5’-TACCTCTGCATTCTTGCGTG), dKdm2-2 (F: 
5’- GGACACGCTGGTTACCTGTT; R: 5’-ATAACCACACGCAATGCAAA).  The 
PCR reactions were performed using the dKdm2 cDNA as the template.  The PCR 
products were purified, sub-cloned into pGEM-T vector (Promega), and verified by 
sequencing.  The primers with T7 sequences are following: T7-dKdm2-1 (F: 5’-
CTAATACGACTCACTATAGGGAGGTTCTCTCTGG; R: 5’- 
CTAATACGACTCACTATAGGGAGTACCTCTGCATTC), T7-dKdm2-2 (F: 5’- 
CTAATACGACTCACTATAGGGAGGGACACGCTGG; R: 5’- 
CTAATACGACTCACTATAGGGAGATAACCACACGC).  The S2-DRSC cell line 
was obtained from the Drosophila Genomics Resource Center (Bloomington, IN).  As 
verified by Western blot, both dKdm2-dsRNAs effectively depleted dKDM2 proteins in 
S2-DRSC cells after 4 days of treatment. 
 14 
 
3. RESULTS*  
 
3.1 Characterization of the conserved protein domains in KDM2 homologs  
 
 
 
Figure 1. Characterization of the conserved protein domains in KDM2 homologs.  
(A) Phylogenetic tree of KDM2 proteins in multicellular animals.  This tree was built 
with MEGA 5 by pairwise algorithm and the Neighbor-Joining algorithm.  The right side 
summarizes the presence (marked with a ‘+’) or absence (marked with a ‘-’) of the 
conserved domains, including JmjC, CXXC zinc finger, PHD, F-box and LRRs/Amn1 
domains.  The NCBI Reference Sequence number and the protein-protein BLAST 
(BLASTp) search results for the putative conserved domains for each KDM2 homolog 
are presented in the Fig. 2.  (B) The domain organization of dKDM2, note that except a 
clear PHD domain, all the other four major domains are present in dKDM2.   
                                                
* Reprinted from Mechanisms of Development, 133, Yani Zheng, Fu-Ning Hsu, Wu Xu, Xiao-Jun Xie, 
Xinjie Ren, Xinsheng Gao, Jian-Quan Ni, Jun-Yuan Ji, A developmental genetic analysis of the lysine 
demethylase KDM2 mutations in Drosophila melanogaster, 36-53, Copyright (2014), with permission 
from Elsevier. 
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KDM2 is conserved in yeast and multicellular animals, especially in the JmjC 
domain (Tsukada et al., 2006).  Interestingly, KDM2 is not present in plants (Zhou and 
Ma, 2008).  There are two KDM2 paralogs in vertebrates and one KDM2 homolog in 
invertebrates (Fig. 1A).  Although the amino-acid sequence and domain structures of  
KDM2 proteins are not completely conserved from yeasts to humans, they share the 
JmjC domain, a CXXC Zinc finger, an F-box domain, and an Amn1 (Antagonist of 
mitotic exit network protein 1) domain that usually overlaps with leucine-rich repeats 
(LRRs) (Cloos et al., 2008; Dui et al., 2012; Jin et al., 2004; Tsukada et al., 2006).   
To portray the evolutionary history of these different domains of KDM2, we built 
a phylogenetic tree of KDM2 proteins in a few representative multicellular animals.  The 
KDM2 proteins from C. elegans to humans share the JmjC domain, which encodes the 
histone demethylase motif (Fig. 1A and Fig. 2).  However, the C. elegans KDM2 lacks 
all other domains found in KDM2.  Interestingly, the PHD finger can be found in 
vertebrates and vase tunicate (Ciona intestinalis), a urochordate (sea squirt), but it is not 
present in purple sea urchin (Strongylocentrotus purpuratus), which belongs to 
Echinodermata, and other invertebrates (Fig. 1A).  In addition, although a KDM2A-like 
protein was annotated in purple sea urchin, this KDM2A-like protein only share the 
similarity in its CXXC zinc finger with other KDM2 proteins (Fig. 1A), suggesting that 
the sea urchin KDM2B-like protein is likely the only KDM2 protein that has 
demethylase activity.  Therefore, besides JmjC domain, the CXXC zinc finger, F-box 
and LRRs/Amn1 domains are highly conserved in KDM2 proteins.   
Unlike vertebrates, Drosophila contains only one ortholog of KDM2, encoded by 
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Figure 2. The NCBI Reference Sequence number and the protein-protein BLAST 
(BLASTp) search results for the putative conserved domains for each KDM2 
proteins that were used in generating the phylogenetic tree presented in Fig. 1A. 
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Figure 2 Continued. 
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CG11033 or dKdm2 gene (Kavi and Birchler, 2009; Lagarou et al., 2008).  As shown in 
Panel B of the figure on Page 14, except the least conserved PHD finger, dKDM2 
contains all the other conserved domains, including JmjC, CXXC zinc finger, F-box and 
the Amn1/LRRs domains.  These features make Drosophila an attractive experimental 
system to genetically dissect the function and regulation of KDM2 during development. 
 
3.2 Expression of dKDM2 during Drosophila development 
To study the role of KDM2 in development, we characterized the expression of 
dKdm2 during developmental stages by quantitative reverse transcriptase PCR (qRT-
PCR) assay.  Based on the high throughput sequencing analysis (Graveley et al., 2011), 
dKdm2 locus encodes 4 transcripts that only differ in their exon 1 that encodes part of 
the 5’ untranslated region (5’ UTR).  Each isoform of dKdm2 transcript contains six 
exons separated by five introns (Fig. 3A).  The exon 1 and part of exon 2 encode the 5’ 
UTR, while part of exon 6 encodes the 3’ UTR (Fig. 3A).  Because dKdm2 gene 
contains six exons that span ~ 11 kb of genomic DNA, we designed three pairs of 
primers that span three exon-exon junctions of the dKdm2 gene: “dKdm2-23” spans the 
exon 2 and exon 3, “dKdm2-34” spans the exon 3 and exon 4, and “dKdm2-56” spans 
the exon 5 and exon 6 (Fig. 3A).  As shown in Fig. 3B, high levels of dKdm2 mRNA 
were detected during the embryonic, third instar larval, pupal stages, as well as in adult 
flies.   
To analyze dKDM2 protein, we first generated a polyclonal rabbit antibody using 
a peptide (AA 37~56) of dKDM2 as the antigen (see Materials and Methods).  We then  
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Figure 3. Expression of dKDM2 during noraml Drosophila development.  (A) 
Schematic view of the dKdm2 locus, showing the 6 exons with the coding exons in 
orange and UTR regions in grey.  The three pairs of the primers used in qRT-PCR assay 
are shown below, and they all span the neighboring exons.  (B) Quantitative RT-PCR 
analysis of relative expression of dKdm2 mRNA during development. L1, first instar 
larvae; L2, second instar larvae; ML3, mid-third instar larvae; L3, third instar larvae; 
WP, white pupae; YP, yellow pupae. (C ~ E) Sub-cellular localization of the dKDM2 
protein assayed with immunoblotting using a polyclonal antibody.  dKDM2 protein is 
present in the nuclear soluble fraction (C), and the dKdm2 deletion line Df(3R)J16 (see 
below) homozygous larvae was used as a negative control. dKDM2 protein is not 
present in the nuclear insoluble fraction (D) and the cytoplasmic fraction (E). (F) Levels 
of the dKDM2 protein in the nuclear soluble fraction of extract from different 
developmental stages. E, embryos; MA, male adults; FA, female adults. Equal total 
amount of proteins were loaded in each lane.  The non-specific bands are marked with 
‘*’, and anti-Actin was used as a control.  
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Figure 4. The Coomassie blue staining (left) of the GST-dKDM2 (AA1-220) fusion 
protein expressed in E. coli, note the expected band of ~52.2 kDa.  This band can be 
strongly recognized by our polyclonal dKDM2 antibody, as shown by Western blot 
(right).  This GST-dKDM2 (AA1-220) fusion protein was used to purify the polyclonal 
dKDM2 antiserum, which was used for the Western blots presented in this work. 
 
 
purified the antiserum using AA1~220 of dKDM2 fused with GST (Fig. 4: Coomassie 
blue staining), which can be recognized by the polyclonal antibody (Fig. 4).  We further 
validated the specificity of this antibody using the null mutants of dKdm2 (Panel H of 
the figure on Page 30) and cultured S2-DRSC cells with dKDM2 depleted (Panel G of 
the figure on Page 30).  With this purified antibody, we analyzed the subcellular 
localization of dKDM2 by separating proteins in the cytosol, nuclear soluble and nuclear 
insoluble fractions from the third instar larvae, since this polyclonal antibody did not 
work with immunostaining.  We observed that dKDM2 is a little bit over 150 kDa on the 
immunoblot after SDS-PAGE (Fig. 3C and Fig. 3F), while dKDM2 is predicted to be 
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146.2 kDa considering composing of 1,345 AA, presumably due to post-translational 
modifications.  Importantly, dKDM2 is only present in the nuclear soluble fraction from 
the wild type but not the mutant larvae (See Panel C of the figure on Page 19).  In 
addition, dKDM2 is not present in the cytosolic and nuclear insoluble fractions (Panel D 
and E of the figure on Page 19, and Panel E of the figure on Page 16), suggesting that 
dKDM2 is a nuclear protein. 
Next, we analyzed the levels of nuclear dKDM2 in different developmental 
stages.  As shown in Panel F of the figure on Page 19, the levels of dKDM2 protein is 
high in embryos, but it is almost undetectable in the first and second instar larvae, and 
subsequently it reappears during the third instar, pupal and adult stages.  This pattern of 
the dKDM2 protein is similar to its mRNA profile during development (Panel B of the 
figure on Page 19), suggesting that dKDM2 may function during embryogenesis and in 
biological processes after the third instar larvae.   
 
3.3 Generation and characterization of the chromosomal deletions around the 
dKdm2 locus  
To understand the function and regulation of dKDM2 during development, it is 
essential to analyze the phenotypic consequences when dKdm2 is mutated.  Since no null 
allele of dKdm2 was available, we generated three deficiency lines in dKdm2 locus using 
the FLP-FRT deletion approach (Parks et al., 2004).  This method takes the advantage of 
the large collection of isogenic piggyBac and P-element insertion lines that contain FRT 
sites (Thibault et al., 2004), expression of flipase recombinase in transheterozygous of  
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Figure 5. Generation and validation of three deletion lines Df(2R)J15, Df(2R)J16, 
and Df(2R)J18 in the dKdm2 locus. (A) Schematic representation of dKdm2 locus and 
its neighboring genes including Mst85C, beag and Ada.  The lower part of the figure 
shows the three new deletions (bars in grey) generated using four piggyBac insertion 
lines (blue) and the primers (green arrow) used for their validation.  These deletions 
were validated by the two-sided PCR (B).  Note that the extension time for PCR reaction 
was set so that only short templates (less than 5.0kb, when deletions occur in the 
deficiency lines) can be amplified. These deficiency lines were further verified using the 
hybrid PCR (C) and the results are shown in (D). In this assay, PCR products can be 
detected only when residual piggyBac transposons are present in the expected 
orientation.    
 
two insertions flanking a genomic region of interest efficiently removes the genomic 
region with precisely defined endpoints (Parks et al., 2004).  The dKdm2 gene is ~11kb 
long and localized in cytogenetic region 85C3-85C4 of third chromosome (Fig. 5A).  To 
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delete the dKdm2 gene, we used several piggyBac (f02828 and e01422) and P-element 
(d06162 and d06730) insertion lines inside of or flanking the dKdm2 locus (Fig. 5A).  
After verification and confirmation of the reported insertion sites and orientation of these 
lines (data not shown), we generated three deletion lines, designated as “Df(3R)J15”, 
“Df(3R)J16”, and “Df(3R)J18” (Fig. 5A).  Of these deletions, Df(3R)J15 removes 
~3.6kb of the dKdm2 gene between d06162 and f02828, while Df(3R)J16 deletes ~12kb 
of the genomic region between d06162 and e01422, which includes dKdm2 and its 
neighboring gene beag (CG18005 at 85C4, Fig. 5A).  Since the endpoint of Df(3R)J16 is 
very close to gene Ada (CG11994 at 85C4, encodes the Adenosine deaminase), this 
deletion may also affect the expression of Ada (see below).  Similarly, Df(3R)J18 is 
smaller than Df(3R)J16, it deletes the ~7.5kb region between d06730 and e01422, 
including both dKdm2 and beag (Fig. 5A).  
We used two methods for the PCR verification of deficiency lines in 
heterozygous adult flies (Df(3R)J15/TM6B Tb, Df(3R)J16/TM6B Tb, and 
Df(3R)J18/TM6B Tb).  First, we performed genomic PCR using primers flanking the 
deleted regions (Fig. 5A).  Short elongation time was set so that only the deletions with 
the short leftover of transposons (<5kb) were amplified.  As shown in Fig. 5B, a PCR 
fragment of expectation size was amplified in the deficiency lines (Df(3R)J15/TM6B Tb, 
Df(3R)J16/TM6B Tb and Df(3R)J18/TM6B Tb), while no PCR product amplified in 
control (w1118) when using primers for Df(3R)J16/TM6B Tb and Df(3R)J18/TM6B Tb.  
Second, we used the hybrid PCR method to amplify the hybrid leftovers of the two 
transposons after recombination (Fig. 5C) (Parks et al., 2004).  As shown in Fig. 5D, the 
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transposon leftover PCR products were amplified in these deficiency lines but not in the 
control, suggesting that these deletions are located in the expected genomic regions.  In 
addition, to precisely map the breakpoints of these deficiency lines, we sequenced the 
PCR products from the genomic PCR (Fig. 5B).  We found that Df(3R)J15 deleted the 
region 4878938 ~ 4882546 of the third chromosome, Df(3R)J16 deleted the region 
4878938 ~ 4890949, while Df(3R)J18 deleted the region 4883430 ~ 4890949, which are 
exactly as what we expected from the insertion sites.   
Taken together, these analyses demonstrate that Df(3R)J15 removes part of the 
dKdm2 gene, while Df(3R)J16 and Df(3R)J18 delete both dKdm2 and its neighboring 
gene beag (Fig. 5A).  Interestingly, the homozygous mutants of Df(3R)J15 are 
completely lethal during the first instar, while the homozygous mutants of Df(3R)J16 
and Df(3R)J18 develop slower but are lethal during third instar larval and pupal stage.  
This appears puzzling considering that Df(3R)J16 and Df(3R)J18 are larger deletions 
than Df(3R)J15 (Fig. 5A), thus we further analyzed these deletion lines together with 
additional dKdm2 alleles described below. 
 
3.4 Characterization of additional dKdm2 alleles caused by insertions of 
transposable elements  
Analyzing multiple alleles of the gene of interest is essential to reveal the 
spectrum of its function during development.  While generating and analyzing the 
deletion lines, several transposon insertion lines within the dKdm2 locus were made 
available from the Bloomington Drosophila Stock Center.  These include dKdm2EP3093  
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Figure 6. Validation of the five dKdm2 alleles generated by insertion of transposable 
elements. (A) Schematic representation showing the insertion sites of the five insertion 
lines (d00170, DG12810, EP3093, EY01336, and KG04325) within the dKdm2 locus.  
The EP3093 line was validated using the two-sided PCR approach (B, showing the 
primers P3 and P4) and the results is shown in (C).  The other four insertion lines were 
verified by the genomic PCR approach (D, showing the primers P5 and P6) and the 
results are shown in (E).  Since the transposons are larger than 10kb, only the wild-type 
gDNA (has no insertions) allow the PCR amplification of products that are less than 2kb.  
Lower panels in C and E are positive controls using the dKdm2-34F and dKdm2-56R 
primers (2682bp apart, as shown in Panel A of the figure on Page 19 and Panel A of the 
figure on Page 22) and the same gDNA samples that were used in the upper panels.  A 
2682bp PCR product was expected from these reactions.  
 
(P[EP]dKdm2EP3093), dKdm2KG04325 (P[SUPor-P]dKdm2KG04325), dKdm2DG12810 
(P[wHy]dKdm2DG12810), dKdm2EY01336  (P[EPgy2]dKdm2EY01336), and dKdm2F11.1  
(P[ID.GAL4DBD]dKdm2F11.1) (Bellen et al., 2004; Gohl et al., 2011; Huet et al., 2002; 
Myrick, 2005) (Fig. 6A).  Although the insertion sites for some of these lines have been 
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vetted by high throughput methods, no developmental genetic analyses of these alleles 
have been reported to date.  In addition, the phenotypic consequences of these mutants 
differ from each other and from the deficiency lines that we generated.  Therefore, it is 
important to validate these mutant alleles before any further analysis.   
To verify the insertion sites, we performed PCR assays using the genomic DNA 
of these alleles as the templates.  For dKdm2EY01336 allele, we used the two-sided PCR 
strategy (Fig. 6B, (Parks et al., 2004)) and confirmed the presence of the insertion (Fig. 
6C).  For the rest of the insertion lines, we used the genomic PCR approach (Fig. 6D).  
Insertions of 10-15kb transposons will not allow the amplification of the gDNA 
fragments between 600bp and 1.5kb, and our results confirmed all these alleles (Panel E 
of the figure on Page 22).  In addition, we also validated five insertion lines generated by 
Exelixis (Thibault et al., 2004), including one piggyBac (PBac[WH]dKdm2f02828) and 
four P-element (P[XP]dKdm2d00170, P[XP]dKdm2d02926, P[XP]dKdm2d06162, and 
P[XP]dKdm2d06730) insertion lines (Panel A of the figure on Page 22, Fig. 6A, and data 
not shown).  Taken together, these results confirmed the reported insertion sites of these 
insertion lines.  
Next, we analyzed homozygous mutants of these 10 insertion lines.  As 
summarized in Table 1, we observed that the homozygous dKdm2EP3093 mutants are 
lethal during the first instar; the dKdm2d00170 mutants are lethal during late third instar, 
while the dKdm2DG12810 mutants are lethal at the pupal stage.  However, the homozygous 
of all the other seven insertion lines are fully viable (Table 1).  
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Based on the lethal phase of the homozygous mutant animals, we classified all 
the 13 available dKdm2 alleles into three classes (Table 1).  The homozygous mutants of 
the class I alleles, including Df(3R)J15, dKdm2EP3093, and dKdm2f02828, are lethal during 
the first instar larval stage (L1).  The homozygous mutants of the class II dKdm2 alleles 
develop slower, and all of them are lethal during the third instar larval (L3) stage, or 
pupal (P) stage, or both (Table 1).  The class II alleles include Df(3R)J16, Df(3R)J18, 
dKdm2d00170, and dKdm2DG12810.  In contrast to these two classes, the mutant animals of 
the class III dKdm2 alleles, including dKdm2d02926, dKdm2d06162, dKdm2d06730, 
dKdm2EY01336, and dKdm2F11.1, and dKdm2KG04325, are fully viable and fertile, and we did 
not observe any developmental defects with these homozygous mutants (Table 1). 
 
3.5 Complementation tests of the multiple dKdm2 alleles 
Because homozygous mutants of multiple alleles of dKdm2 are either fully viable 
or lethal during larval and pupal stages, we performed complementation test and 
analyzed the viability of transheterozygous combinations of any of two dKdm2 alleles.  
As summarized in Table 1, we found that transheterozygous combination of dKdm2f02828 
and Df(3R)J15 (genotype: w1118; +; dKdm2f02828/Df(3R)J15) are lethal during L1 stage, 
similar to homozygous mutants of either dKdm2f02828 or Df(3R)J15.  Since Df(3R)J15 
was generated by removing the genomic regions between dKdm2f02828 and dKdm2f06162, 
these two lines share similar genetic background and they are further analyzed below.  In 
addition, we observed that transheterozygous combination of Df(3R)J16 and Df(3R)J18 
(genotype: w1118; +; Df(3R)J16/Df(3R)J18) are lethal during L3 and pupal stage, similar 
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Table 1 Summary of the complementation genetic tests of the dKdm2 alleles at 25°C 
               
  Alleles Df(3R)J15   f02828  EP3093  d00170 Df(3R)J16   Df(3R)J18 DG12810  d02926 d06162 d06730 EY01336 F11.1 KG04325 
Class 
I 
 Df(3R)J15   lethal (L1)             
 f02828  lethal (L1) lethal (L1)            
  EP3093  viable viable lethal (L1)                     
Class 
II 
 d00170 viable viable viable lethal (L3)          
 Df(3R)J16   viable viable viable viable lethal  (L3/P)         
 Df(3R)J18  viable viable viable viable Lethal  (L3/P) 
lethal  
(L3/P)        
  DG12810  viable viable viable viable viable viable lethal (L3/P)             
Class 
III 
  d02926 viable   viable   viable   viable   viable   viable   viable   viable           
 d06162 viable   viable   viable   viable   viable   viable   viable   viable viable     
 d06730 viable   viable   viable   viable   viable   viable   viable   viable viable viable    
 EY01336 viable   viable  viable  viable viable  viable   viable   viable viable viable viable   
 F11.1 viable viable viable viable viable  viable  viable  viable viable viable viable viable  
  KG04325 viable   viable   viable   viable   viable   viable   viable   viable   viable   viable   viable  viable viable 
                
E: embryonic stage; L1: first instar larval stage; L3: third instar larval stage; P: pupal stage 
 
 
to homozygous mutants of either Df(3R)J16 or Df(3R)J18 alone (Table 1).  Other than 
these two exceptions, however, all of the transheterozygous combinations of other 
dKdm2 alleles are fully viable, fertile, and showed no developmental delays (Table 1). In 
fact, the transheterozygous combinations of dKdm2 alleles can be maintained as stocks 
for generations (data not shown), indicating that dKDM2 is not essential for normal 
development of both somatic and germline cells, which will be further analyzed below. 
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3.6 Effects of dKdm2 alleles on the expression of dKdm2 and its neighboring genes  
If dKdm2 is not required for normal development, why are the class I and class II 
alleles of dKdm2 lethal during the larval and pupal stages?  One possibility to explain 
why the transheterozygous animals among class I and class II dKdm2 alleles are fully 
viable is that the expression of dKdm2 is normalized when these alleles were paired in 
trans, possibility through mechanisms such as transvection, or paring-dependent 
intragenic complementation (Kennison and Southworth, 2002; Wu and Morris, 1999).  
Several mechanisms have been proposed to explain the heteroallelic complementation, 
including trans-acting regulatory RNAs, trans-splicing of RNAs, and trans-acting 
enhancer element (Kennison and Southworth, 2002; Wu and Morris, 1999).  This 
hypothesis predicts that the expression of dKDM2 is normalized when two defective 
alleles are supplied in trans.  Alternatively, dKDM2 is not required for normal 
development and the lethality of certain alleles are caused by potential second-site 
mutation(s) in the genetic backgrounds, which would have opposite prediction on 
dKdm2 mRNA and protein levels.   
To distinguish these two scenarios, we analyzed the mRNA and protein levels of 
dKdm2 in both homozygous and trans-heterozygous mutants.  First, we analyzed the 
effects of class I and class II dKdm2 alleles on the expression of dKdm2 and its 
neighboring genes, including Mst85C, beag and Ada, by qRT-PCR assay, since these 
neighboring genes may also be affected in some alleles.  Fig. 7A shows the schematic 
view of the dKdm2 locus with its neighboring gene and the relative position of the qPCR  
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Figure 7. Effects of insertions and deletions of the class I and class II dKdm2 alleles 
on the expression of dKdm2 and its neighboring genes. (A) The location of the 
primers used for the qRT-PCR assay.  Animals of the third instar at the wandering stage 
were used for the qRT-PCR (C ~ F) and immunoblots (G and H).  The genotypes of the 
mutants include: w1118; +; Df(3R)J15 (B, first instar laevar), w1118; +; Df(3R)J16 (C), 
w1118; +; Df(3R)J18 (D), w1118; +; dKdm2d00170 (E), and w1118; +; dKdm2DG12810 (F). (G) 
Western blot was used to demonstrate the specificity of the dKDM2 antiserum, note that 
the ~150kDa band is present in the control (w1118) but not in the Df(3R)J16 and 
dKdm2DG12810 mutants.  In addition, this band is present in untreated S2-DRSC cells or 
cells treated with dsRNA to white (control), but disappears in S2-DRSC cells treated two 
different shRNAs targeting dKdm2.  (H) Western blot of nuclear soluble proteins from 
the third instar larvae, showing that dDKM2 protein is undetectable in Df(3R)J16, 
Df(3R)J18, dKdm2d00170 or dKdm2DG12810 homozygous mutants. 
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primers used in this analysis.  Three pairs of primers spanning the exons of dKdm2 locus 
allowed us to exclude amplification from genomic DNA contamination, but also assay 
the effect of transposon insertions within the introns on mRNA expression (Fig. 7A).  
We focused our analysis on homozygous mutants of the one class I Kdm2 alleles 
(Df(3R)J15), four class II dKdm2 alleles, including Df(3R)J16, Df(3R)J18, dKdm2d00170, 
and dKdm2DG12810, as well as a few class III dKdm2 alleles.   
For class I allele Df(3R)J15, we analyzed the homozygous mutants in L1 stage 
since they are lethal in this stage.  We could not detect dKdm2 mRNA with the qPCR 
primers that span the exon 2 and exon 3 of the dKdm2 gene in Df(3R)J15 homozygous 
mutants (Fig. 7B), which is consistent to the complete deletion of exon 2 in Df(3R)J15 
allele.  Surprisingly, however, qPCR primers that monitor exon 3 to exon 6 revealed a 
4~8 fold increase (Fig. 7B), suggesting that a truncated dKDM2 protein may be 
ectopically expressed in the Df(3R)J15 mutants.  We note that the antigen used to 
generate the polyclonal antibody (AA37~56) spans the deleted first exon, preventing us 
from detecting an overexpressing of the truncated dKDM2. 
For class II alleles, we examined the gene expression in the homozygous mutants 
at the wandering (late third instar) stage.  We observed that both dKdm2 and beag are 
not detectable in both Df(3R)J16 (Fig. 7C) and Df(3R)J18 (Fig. 7D) mutant larvae, while 
Mst85C is not affected by these deletions.  Unexpectedly, however, the expression of 
Ada is increased 2~5 folds in these two deletions (Fig. 7C and Fig. 7D).  Perhaps, 
deletion of beag and most part of dKdm2 allows the residual regulatory elements of 
dKdm2 to drive the aberrant expression of Ada (see the table on Page 28).  Since 
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Df(3R)J15 and Df(3R)J16 share the same breakpoint within the first intron of dKdm2 
locus, our observation of upregulation of exons 2-5 of dKdm2 in Df(3R)J15 (Fig. 7B) 
and ectopic expression of Ada in Df(3R)J16 (Fig. 7C) suggests that transcription of 
dKdm2 may be controlled by regulatory elements within the first intron or further 
upstream of the transcription start site.  Similarly, we analyzed dKdm2d00170 homozygous 
mutants and found that dKdm2 mRNA is significantly reduced when detected with three 
sets of dKdm2 primers, but its neighboring genes Mst85C and beag are also reduced 
(Fig. 7E).  Furthermore, we analyzed dKdm2DG12810 homozygous mutants and observed 
that dKdm2 mRNA is significantly reduced compared to the control, and the expression 
of the dKdm2 neighboring genes was not affected (Fig. 7F).  
Besides the mRNA levels of dKdm2 gene, we also analyzed the effects of these 
dKdm2 alleles on dKDM2 protein levels by Western blot.  Since the levels of dKDM2 
protein are high during embryonic, third instar larval, pupal and adult stages (Fig. 3F), 
we analyzed the class II dKdm2 homozygous mutants during the third instar stage and 
found that dKDM2 was undetectable in Df(3R)J16 and dKdm2DG12810 homozygous 
mutants (Fig. 7G and Fig. 7H).  Similar to Df(3R)J16 and dKdm2DG12810 homozygous 
mutants, dKDM2 was also undetectable in Df(3R)J18 and dKdm2d00170 homozygous 
mutants (Fig. 7H).  Taken together, these results suggest that despite both mRNA and 
protein of dKDM2 are very low or undetectable in the class II mutant alleles of dKdm2 
gene, they affect the expression of its neighboring genes, which may be responsible for 
the pupal lethality in these mutant animals.  It is technically difficult to rigorously 
exclude the possibility that the indirect effect of loss of both dKdm2 and beag, together 
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with over-expression of Ada, contributed to the pupal lethality in Df(3R)J16 and 
Df(3R)J18 homozygous mutants. 
Furthermore, we performed similar analyses with four class III dKdm2 alleles, 
including dKdm2d06730, dKdm2EY01336, dKdm2F11.1, and dKdm2KG04325.  Despite insertions  
  
 
 
Figure 8. Analyses of dKdm2 mRNA and dKDM2 protein levels in several class III 
dKdm2 alleles. (A ~ D) shows the results of qRT-PCR analysis of dKdm2 and its 
neighboring genes in dKdm2d06730 (A), dKdm2EY01336 (B), dKdm2F11.1 (C), and 
dKdm2KG04325 (D) homozygous mutants during the wandering stage.  (E ~ H) Results of 
Western blot analysis showing the levels of dKDM2 protein in the dKdm2d06730 (E), 
dKdm2EY01336 (F; Df(3R)J16 mutants were used as the negative control), dKdm2F11.1  (G; 
Df(3R)J16,  Df(3R)J18, and dKdm2DG12810  mutants were used as the control), and 
dKdm2KG04325 (H) homozygous third-instar wandering larvae. 
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of large transposons in the third intron of dKdm2 locus (See the figure on Page  25), we 
observed that the levels of dKdm2 and its neighboring genes are not significantly 
affected (Fig. 8A ~ 8D).  Consistent with this observation, the levels of dKDM2 protein 
are also not affected in these alleles (Fig. 8E ~ 8H).  Therefore, these class III alleles 
should not be considered as the mutant alleles of dKdm2.   
 
3.7 Expression of Kdm2 and its neighboring genes in trans-heterozygous mutants  
Next, we performed similar analyses by focusing on a few trans-heterozygotic 
combinations that are fully viable.  We observed that the exon 2 of dKdm2 was 
undetectable in Df(3R)J15/Df(3R)J16 (Fig. 9A), Df(3R)J15/Df(3R)J18 (Fig. 9B), 
Df(3R)J15/ dKdm2DG12810 (Fig. 9C) mutants, which is similar to Df(3R)J15 homozygous 
mutants, while the exon 3 and exon 4 levels are normalized in Df(3R)J15/Df(3R)J16 
(Fig. 9A) and Df(3R)J15/Df(3R)J18 (Fig. 9B) mutants, but not affected in Df(3R)J15/ 
dKdm2DG12810 (Fig. 9C) mutants.  The expression pattern of dKdm2 neighboring genes 
(Fig. 9A ~ 9C) is consistent with expectations based on what we observed in 
homozygous mutants (See the figure on Page 19).  Similarly, we examined the dKdm2 
expression in Df(3R)J16/Df(3R)J18 (Fig. 9D), Df(3R)J16/dKdm2DG12810 (Fig. 9E), and 
Df(3R)J18/dKdm2DG12810 (Fig. 9F) transheterozygous mutants, and we observed that all 
exons of dKdm2 were undetectable in these combinations.  The major difference among 
these three combinations is the expression of beag (Fig. 9D vs. Fig. 9E/F), which is 
deleted in Df(3R)J16/Df(3R)J18 mutants.  Unlike Df(3R)J16/Df(3R)J18 mutants, 
Df(3R)J16/dKdm2DG12810 and Df(3R)J18/dKdm2DG12810 animals are fully viable (see the  
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Figure 9. Expression of dKdm2 and its neighboring genes in transheterozygous 
combination of several class I and class II dKdm2 alleles.  All animals were collected 
during the third instar at the wandering stage. The genotypes include: w1118; +; 
Df(3R)J15/Df(3R)J16 (A), w1118; +; Df(3R)J15/Df(3R)J18 (B), w1118; +; 
Df(3R)J15/dKdm2 DG12810 (C), Df(3R)J16/Df(3R)J18 (D), w1118; +; Df(3R)J16/dKdm2 
DG12810 (E), w1118; +; Df(3R)J18/dKdm2 DG12810 (F), w1118; +; Df(3R)J18/dKdm2 d00170 
(G), and w1118; +; dKdm2d00170/dKdm2DG12810 (H). (I) Western blot of nuclear soluble 
proteins from these transheterozygous mutant animals at the wandering stage, note that 
dKDM2 protein was not detectable, except in the w1118; +; dKdm2EP3093/dKdm2f02828 
mutants, which is due to the fact that the level of dKdm2 mRNA is not obviously 
affected in these mutants (Fig. 10E).  The Df(3R)J16 homozygous mutants (denoted as 
“J16/J16”) was used as a control; the arrow shows the dKDM2 band, and the non-
specific band is marked with a “*”. 
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Figure 9 Continued. 
 
table on Page 28), suggesting that the pupal lethality of Df(3R)J16/Df(3R)J18 
heterozygous, as well as Df(3R)J16 and Df(3R)J18 homozygous mutants are likely due 
to loss of beag but not loss of dKdm2 or ectopic gain of Ada.  Moreover, we analyzed 
the expression of these genes in Df(3R)J18/dKdm2d00170 (Fig. 9G) and 
dKdm2d00170/dKdm2DG12810 (Fig. 9H) and In addition, we examined the levels of dKDM2 
protein in several heteroallelic combinations, including Df(3R)J15/Df(3R)J16, 
Df(3R)J16/Df(3R)J18, Df(3R)J16/dKdm2d01700, Df(3R)J18/dKdm2DG12810, 
dKdm2d00170/dKdm2DG12810, Df(3R)J15/ dKdm2DG12810, dKdm2d00170/dKdm2f02828, and 
dKdm2EP3093/dKdm2f02828 during the third instar wandering stage.  Using the Df(3R)J16 
homozygous as a control, we observed that dKDM2 proteins are undetectable in these 
transheterozygous mutants, except the dKdm2EP3093/dKdm2f02828 mutants (Fig. 9I).  
These results are consistent to dKdm2 RNA levels in these heteroallelic combinatins 
(Fig. 10).  Taken together, the results from these genetic, molecular and biochemical 
analyses argue against the possibility of transvection between the class I and class II 
dKdm2 alleles, thus the most parsimonious explanation of these observations is that 
dKdm2 may be not required for fly viability.  
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3.8 Potential second-site mutation(s) in the class I and class II dKdm2 alleles  
One observation against the conclusion that dKdm2 is not essential for normal 
development is that several of the homozygous mutants of class I and class II dKdm2 
alleles are lethal during L1, L2 or pupal stages (see the table on Page 28).  For example, 
the homozygous mutants of dKdm2f02828 and dKdm2EP3093 alleles are lethal during L1 
(see the table on Page 28).  Similarly, dKdm2d00170 and dKdm2DG12810 are lethal 
 
 
 
Figure 10. qRT-PCR analyses of dKdm2 mRNA levels in several transheterozygous 
combinations of the dKdm2 alleles.  The genotypes include w1118; +; 
Df(3R)J15/dKdm2d00170 (A), w1118; +; Df(3R)J16/dKdm2d00170 (B), w1118; +; 
dKdm2d00170/dKdm2f02828 (C), w1118; +; Df(3R)J16/dKdm2f02828 (D), and w1118; +; 
dKdm2EP3093/dKdm2f02828 (E).  
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during L3 and pupal stages, and these two alleles disrupted dKdm2, but have little or 
only mild effects on dKdm2 neighboring genes (See Pane E and F of the figure on Page 
30).  If dKdm2 is not required for normal development, one possible explanation for the 
lethality of these alleles is that they are caused by recessive mutation(s) in the genetic 
backgrounds of these alleles.   
 
Table 2 Summary of the complementation genetic tests of the dKdm2 alleles after 
generations of outcrossing with wild-type (w1118) flies 
            
Alleles Df(3R)J15   f02828#  EP3093#  d00170# 
 f02828# viable lethal (L3/P)     
 EP3093# viable viable viable  
 d00170# viable viable viable viable 
L3: third instar larval stage; P: pupal stage 
 
To remove the potential recessive mutations in these four alleles, we outcrossed 
them with wild-type (w1118 strain) flies for four generations and the cleaned alleles are 
denoted by adding ‘#’ after these alleles (Table 2).  We observed that instead of lethal 
during larval stage (L1 or L3), the dKdm2EP3093# and dKdm2d00170# homozygous mutants 
become fully viable (Table 2), suggesting that the original transposon insertion lines 
indeed harbor unknown second site mutation(s).  The presence of the transposon 
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Figure 11. Verification of several transposon insertion lines after four generations 
of outcrossing with w1118 flies.  (A) The dKdm2f02828, dKdm2d00170 and dKdm2EP3093 
alleles were verified by genotype PCR using the same scheme illustrated in Pane D of 
the figure on Page 25, and the dKdm2EP3093 allele was also validated using hybrid PCR 
similar to Pane C of the figure on Page 22.  To distinguish with their corresponding 
parental alleles, each allele is marked with “#”.  (B ~ D) qRT-PCR analyses of the 
cleaned dKdm2 alleles to examine the levels of dKdm2 and its neighboring genes, and 
the genotypes include w1118; +; dKdm2f02828# (B), w1118; +; dKdm2d00170# (C), and w1118; 
+; dKdm2EP3093# (D).  (E) The levels of dKDM2 protein in these mutants detected by 
Western blot.   All of the homozygous animals are selected at the L3 wandering stage. 
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Figure 12. Validation and characterization of the Df(3R)J15# allele after 
outcrossing.  Schematic representations of genomic PCR (A) and hybrid PCR (C), and 
the results are shown in B and D, respectively, in two independently outcrossed line 
Df(3R)J15#, designated as “J15#-1” and “J15#-2”.  The “J15#-1” line was used for 
subsequent analyses.  (E) Expression of dKdm2 and its neighboring genes assayed by 
qRT-PCR. 
   
 
insertions of these alleles in the cleaned homozygous mutants was verified again by PCR  
and qRT-PCR analyses (Fig. 11).  In addition, unlike the L1 stage lethal of the original 
line, dKdm2f02828# homozygous mutants are lethal during L3 and pupal stage, this 
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improvement also suggest additional mutations in the genetic background.  However, the 
dKdm2DG12810# homozygous mutants are still pupal lethal.  Perhaps the recessive lethal 
mutations are very close to dKdm2f02828# and dKdm2DG12810# alleles and four generations 
of outcrossing was not sufficient to completely separate the unknown recessive lesions 
from these two dKdm2 alleles.  This possibility is supported by the observation that 
dKdm2f02828#/Df(3R)J15 animals are fully viable (see the table on Page 38), instead of L1 
lethal prior to outcrossing (see the table on Page 28).   
In addition, we outcrossed the Df(3R)J15 line and found that homozygotes of 
Df(3R)J15# allele become fully viable.  The PCR verifications of two independently 
outcrossed Df(3R)J15# lines are shown Fig. 12A ~ 12D.  Analysis of the mRNA levels 
of dKdm2 in the third instar homozygous Df(3R)J15# larvae (Fig. 12E) revealed similar 
expression pattern to the first instar larvae of the homozygous Df(3R)J15 mutants (Pane 
B of the figure on Page 30).  Df(3R)J15 removes the exon 2 of dKdm2, which encodes 
the AA1~44 of dKDM2 protein (Pane A of the figure on Page 22).  The Western blot 
analysis did not reveal an extra truncated dKDM2 protein with 1301AA (exons 3~6) in 
Df(3R)J15/Df(3R)J16 and Df(3R)J15/ dKdm2DG12810 larvae (Pane I of the figure on Page 
35), indicating that Df(3R)J15 is likely a dKdm2 null allele.   
 
3.9 Effects of loss of dKdm2 on histone lysine modifications 
The functions of KDM2 in Drosophila and mammalian cells are still 
controversial.  The mammalian KDM2A and KDM2B were found to function as an 
H3K36me2/me1 demethylase (He et al., 2008; Lagarou et al., 2008; Tsukada et al., 
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2006; Tzatsos et al., 2009), but no effect of KDM2B on H3K4me3 was observed (He et 
al., 2008).  However, KDM2B was also reported to demethylate H3K4me3 instead 
(Frescas et al., 2007; Janzer et al., 2012; Tzatsos et al., 2009).  Similarly, data from 
Drosophila also appear contradictory: dKDM2 was reported to target H3K36me2, but 
not H3K36me1/me3 and H3K4me3, when dKDM2 is depleted in S2 cells (Lagarou et 
al., 2008); however, dKDM2 was also reported to target H3K4me3 in larvae with 
dKdm2-depleted by expressing dsRNA targeting dKdm2 under control of act5C-Gal4, 
but has no effect on H3K4me2, H3K9me2 and H3K36me2 (Kavi and Birchler, 2009).  
Perhaps, the differences are dues to different experimental approaches.  For example, the 
data from mammalian cells are based on overexpression of wild-type KDM2B, and the 
effects of depletion of KDM2B on histone methylation remain unclear.  Alternatively, 
KDM2 may present in different protein complexes at different developmental stages or 
in different tissues.    
          To clarify the exact role of dKDM2 in vivo, it is important to analyze the status of 
histone methylation in loss of dKdm2 mutant animals.  Therefore, we first focused on 
two homozygous mutants of class II dKdm2 alleles, Df(3R)J16 and Df(3R)J18.  As 
shown in Fig. 13A, we observed that the levels of H3K36me1/2/3 are increased in the 
Df(3R)J16 and Df(3R)J18 homozygous mutants during the third instar larval stage.  In 
contrast, the levels of H3K4me3 were weakly affected in the mutants, while the levels of 
H3K4me1/me2, H3K9me2 and H3K27me2/me3 were not affected in the mutants 
compared to the control (Fig. 13A).  Similar observations were made with dKdm2DG12810, 
and to a less extent, dKdm2d00170 homozygous mutants (Fig. 13B).  In addition, we 
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analyzed the histone modification in dKdm2DG12810/Df(3R)J16  and 
dKdm2DG12810/Df(3R)J18  transheterozygous larvae and found that only H3K36me1/2 are 
affected (Fig. 13C).  
For the following two reasons, we cannot rigorously conclude that the effects of 
Df(3R)J16 and Df(3R)J18 on H3K4me and H3K36me are due to loss of dKDM2: first, 
 
 
 
Figure 13. Effects of loss of dKdm2 on histone lysine modifications as assayed by 
Western blots. (A) The levels of histone modifications in the Df(3R)J16 and Df(3R)J18 
homozygous mutants during the third instar wandering stage, and w1118 animals at the 
same stage were used as the control.  Similar Western blot analysis was performed to 
analyze histone modification in the dKdm2d00170 and dKdm2DG12810 homozygous mutants 
(B), as well as the dKdm2DG12810/Df(3R)J16 and dKdm2DG12810/Df(3R)J18 trans 
heterozygous larvae (C).  (D) dKDM2 protein is depleted in S2-DRSC cells using two 
different dKdm2 shRNAs (ds-dKdm2-1 and ds-dKdm2-2), and the effects on histone 
modifications were analyzed by Western blot (E).  The dsRNA to white gene was used 
as the control.  These analyses were repeated multiple times. 
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the Df(3R)J16 and Df(3R)J18 homozygotes are lethal during late L3 and pupal stage (see 
the table on Page 28), both of these alleles delete both dKdm2 and beag but 
simultaneously upregulate the expression of Ada (Pane A of the figure on Page 22, Pane 
C and D of the figure on Page 30).  Second, beag encodes a spliceosomal protein that 
regulates synapse development and neurotransmitter release, and the null mutants 
(beag1/beag1) are semilethal with over 60% of the homozygous mutants die (Beck et al., 
2012).  The exact cause for lethality of the Df(3R)J16 and Df(3R)J18 homozygotes is a 
thorny problem, which can be caused by loss of dKdm2 and beag, overexpression of 
Ada, potential recessive mutations in the background, or different combinations of these 
issues. 
To complement these in vivo analyses, therefore, we examined the effect of 
depletion dKDM2 using two different dsRNAs specifically targeting dKDM2 in cultured 
Drosophila S2-DRSC cells.  These two dsRNAs are effective in depleting dKDM2 
protein after 4 days of treatment (Fig. 13D).  Compared to the control cells that were 
treated with shRNA targeting white gene, depletion of dKDM2 did not affect the 
methylation levels of H3K4me1/me2/me3, H3K36me1/me2/me3, H3K9me2, or 
H3K27me2/me3 (Fig. 13E).  Perhaps the residual dKDM2 proteins are sufficient to 
maintain the normal levels of methylation at these sites.  Taken together, these 
observations show that the role of dKDM2 in regulating H3K4me and H3K36me 
appears rather weak during the larvae stage, suggesting that dKDM2 may be redundant 
with other histone lysine demethylases during development.  
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4. DISCUSSION*  
 
The past two decades have witnessed an explosion of information regarding how 
histone lysine methyltransferases and demethylases, especially the biochemical 
mechanisms underlying the activities of these enzymes, contribute to the regulation of 
gene expression.  However, the regulation and functions of these enzymes during 
development and different physiological and pathological contexts remain poorly 
understood.  Here we report our developmental genetic analyses of multiple mutant 
alleles of the lysine demethylase KDM2 in Drosophila, dKdm2.  We found that dKDM2 
is a nuclear protein, and both the mRNA and protein levels of dKDM2 fluctuate during 
Drosophila development.  In addition, our molecular and genetic analyses with multiple 
dKdm2 alleles suggest that dKDM2 is not required for viability.  Furthermore, the effects 
of loss of dKDM2 on H3K4me3 and H3K36me are rather marginal at the third instar 
larval stage.  We did not observe any changes of methylation status on H3K4me1/me2, 
H3K9me2 and H3K27me2/me3 in dKdm2 mutant larvae. 
That dKdm2 is actually not required for viability of Drosophila is supported by 
the complementation genetic tests among all dKdm2 alleles (see the tables on Page 28 
and 38), as well as the molecular and biochemical analyses of the levels of dKdm2 
mRNA and protein levels in both homozygous and transheterzygous combinations of the 
                                                
* Reprinted from Mechanisms of Development, 133, Yani Zheng, Fu-Ning Hsu, Wu Xu, Xiao-Jun Xie, 
Xinjie Ren, Xinsheng Gao, Jian-Quan Ni, Jun-Yuan Ji, A developmental genetic analysis of the lysine 
demethylase KDM2 mutations in Drosophila melanogaster, 36-53, Copyright (2014), with permission 
from Elsevier. 
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dKdm2 alleles (see figures on Page 30, 35, 37 and 39).  However, one would expect that 
dKdm2 is an essential gene for normal Drosophila development for the following 
reasons: First, dKDM2 regulates methylation status of H3K36me2 (Lagarou et al., 
2008), which plays important roles in regulating transcription elongation and DNA 
mismatch repair (Buratowski and Kim, 2010; Li et al., 2013).  Second, dKDM2 was 
identified as a subunit of the dRAF (dRING-associated factors dRING-associated 
factors) complex, and is thought to play pivotal roles to mediate H3K36me2 
demethylation and is required for H2A ubiquitination by dRING in the dRAF complex 
(Lagarou et al., 2008).  Third, as summarized in the Introduction, the mammalian KDM2 
homologs have been shown to regulate stem cell differentiation and dysregulation of 
them are linked to a number of human cancers.  Therefore, the conclusion that dKdm2 is 
not required for viability raises two major questions that warrant further discussion.   
First, if dKdm2 is not essential for viability of Drosophila, technically how can 
we explain the lethality of the class I and the class II dKdm2 mutants?  The class I alleles 
include three dKdm2 alleles (see the table on Page 28).  After outcrossing with the w1118 
line, dKdm2EP3093# and Df(3R)J15# mutants become fully viable, suggesting that the 
lethality of dKdm2EP3093 and Df(3R)J15 homozygotes (the original insertion or deletion 
line, respectively) during L1 is caused by the second site lethal mutation(s).  Consistent 
to this notion, the homozygous mutants of cleaned dKdm2f02828# allele are lethal during 
L3 and pupal stage, instead of the L1 lethal in the original dKdm2f02828 allele (see the 
tables on Page 28 and 38), suggesting that the additional mutation(s) could be too close 
to dKdm2f02828 to be removed by four generations of outcrossing.  Both the original 
 47 
 
Df(3R)J15 homozygotes, which are also lethal during L1 stage (see the table on Page 
28), and the outcrossed Df(3R)J15# homozygotes have significantly elevated expression 
of the exon 3 to exon 6 but not exon 2 of the dKdm2 gene (Panel E of the figure on Page 
40), raising the possibility that the ectoptic expression of a truncated dKDM2 fragment 
may be detrimental to normal development.  However, our immunoblots data of 
Df(3R)J15/Df(3R)J16 and Df(3R)J15/dKdm2DG12810 transheterozygous mutants (Panel I 
of the figure on Page 35) argue against this possibility.  Because dKdm2f02828#/Df(3R)J15 
and Df(3R)J15# homozygous animals are fully viable (see the table on Page 38), we 
favor the alternative explanation that the L1 lethality of the dKdm2f02828 and Df(3R)J15 
mutants is likely due to similar second-site mutations in their shared genetic background 
(see the figure on Page 22).  
The class II allele (Df(3R)J16, Df(3R)J18, dKdm2d00170, and dKdm2DG12810) 
mutants are lethal during L3 and pupal stages (see the table on Page 28).  Rather than 
disruption of dKdm2 alone, the lethality of the Df(3R)J16/Df(3R)J18 animals is likely 
caused by the deletion of beag gene and overexpression of Ada (see the figure on Page 
30), since Df(3R)J16 and Df(3R)J18 delete not only dKdm2 but also its neighboring gene 
beag (Panel A of the figure on Page 19, Panel C and D of the figure on Page 30).  
Similar to dKdm2EP3093# mutants, the cleaned dKdm2d00170# mutants are also fully viable, 
supporting that the original dKdm2d00170 allele harbors recessive lethal mutation(s) in 
their genetic background.  We note that four generations of outcrossing with 
dKdm2DG12810 allele did not improve viability, and we speculate that such lethal 
mutations may be close to dKdm2 and four generations of outcrossing was not sufficient 
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to eliminate them.  Although these analyses suggest that dKdm2 gene is not be required 
for viability, we note that none of existing dKdm2 mutant alleles is perfect to rigorous 
test this, which ultimately requires generation of null dKdm2 alleles without affecting its 
neighboring genes in the future.  
The second major question is: if dKDM2 is not required for the viability of 
Drosophila, why is dKdm2 not lost during evolution and what are the selection pressures 
that keep DKM2 proteins so conserved in multicellular organisms?  We think that there 
are two possible explanations.  First, it is possible that dKDM2 is redundant to other 
histone demethylases, such as dKDM4A (CG15835) and dKDM4B (CG33182).  Besides 
KDM2, KDM4 and KDM8 (JMJD5) have been reported to demethylate H3K36me2 in 
mammals (Crona et al., 2013; Hsia et al., 2010; Ishimura et al., 2012; Lin et al., 2012).  
Although KDM8 homolog does not exist in Drosophila, dKDM4A has been reported to 
demethylate H3K36me2/me3 in vitro (Lin et al., 2008), and its paralog dKDM4B targets 
both H3K36me2/me3 and H3K9me2/me3 (Lin et al., 2008; Tsurumi et al., 2013).  
Interestingly, the dKdm4A null (dKdm4AΔ) homozygous mutants are fully viable, fertile 
and do not display any obvious developmental defects (Crona et al., 2013).  Similarly, 
homozygous mutants of another amorphic allele dKdm4AKG04636, a P-element insertion 
within the first exon of dKdm4A, are also fully viable, but have reduced lifespan in males 
(Lorbeck et al., 2010).  It is thus possible that dKDM2 is redundant with histone lysine 
demethylases such as dKDM4A or dKDM4B, in regulating the methylation status on 
H3K36, which would explain why we only observed rather mild effect of dKDM2 
mutation on H3K36me and H3K4me during the larval stage.  It was previously reported 
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that depleting dKDM2 with dsRNA in S2 cells for 4 days led to increased H3K36me2 
levels (Lagarou et al., 2008).  For reasons that we do not understand, our depletion of 
dKDM2 using two different dsRNAs (648bp and 956bp, respectively) failed to show any 
effect on histone modifications (Panel B of the figure on Page 43).  Perhaps, the dsRNA 
depletion of dKDM2 in S2 cells did not reach the threshold for us to detect the effect on 
histone modification, or due to different expression of histone lysine demethylases 
between the two Drosophila cell lines.  Nevertheless, the potential redundancy between 
dKDM2 and other lysine demethylases may increase the robustness of gene regulatory 
networks during development.  
Second, it is also possible that dKDM2 is required to respond to stresses, such as 
oxidative and genotoxic stresses, considering that phosphoproteomic analysis has 
identified seven serine residues and one tyrosine residue of dKDM2 are phosphorylated 
in Drosophila embryos (Zhai et al., 2008).  However, it is completely unknown as to 
which kinases phosphorylate dKDM2 at what biological contexts.  Interestingly, dKdm2 
mutants are defective in ethanol metabolism and sensitive to ethanol-induced 
hyperactivity (Devineni et al., 2011).  In addition, H3K36me3 was shown recently to 
play a critical role during initiation of DNA mismatch repair (Li et al., 2013).  
Considering the role of KDM2 in regulating H3K36 methylation, it will be interesting to 
examine whether KDM2 is involved in the maintenance of genome stability in response 
to genotoxic and other stresses. Based on our genetic and biochemical analyses of the 
dKdm2 alleles, it will be important to examine if dKDM2 is redundant with other histone 
demethylases and whether dKDM2 is involved in stress responses in the future. 
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5. CONCLUSION  
 
Post-translational modification of histones plays essential roles in the 
transcriptional regulation of genes in eukaryotes. Methylation on basic residues of 
histones is regulated by histone methyltransferases and histone demethylases, and 
misregulation of these enzymes has been linked to a range of diseases such as cancer. 
However, the regulation and regulation of these enzymes during development and 
different physiological and pathological contexts remain poorly understood.  
The work details the first comprehensive genetic analysis multiple alleles of a 
histone demethylase in Drosophila, dKdm2.  We use thorough classic genetic analyses to 
investigate the nature of dKdm2 alleles and discover that dKdm2 mutants, unlike in other 
model systems, are fully viable. The major findings based on our developmental genetic 
analyses of multiple mutant alleles of dKdm2.  First, we found that dKDM2 is a nuclear 
protein and both the mRNA and protein levels of dKDM2 fluctuate during Drosophila 
development.  Second, we then generated three deletion lines in the dKdm2 locus and 
then validated these mutants by PCR and sequencing.  Third, our molecular and genetic 
analyses with these deletion lines and 10 dKdm2 alleles caused by transposon insertions 
show that dKDM2 is not required for viability of the flies.  This is unexpected given the 
importance of KDM2 in regulating H3K36 methylation and the importance of H3K36me 
in affecting transcription elongation. 
In addition, this work resolves existing debate within the field of chromatin 
modification. In Drosophila, two research papers related to dKDM2 have been published 
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in recent years.  However, the role of dKDM2 in histone modification has been 
controversial, owing to the lack of dKdm2 mutants.  By analyzing loss of function 
mutants, we found that dKDM2 specifically demethylates H3K36me during the larval 
stage, but the effect of loss of dKDM2 on H3K4me3 is rather weak.  In addition, loss of 
dKDM2 has no effect on methylation status of H3K4me1/me2, H3K9me2 and 
H3K27me2/me3.  These results suggest the dKDM2 is likely to be redundant with other 
histone lysine demethylases, significantly clarifying the conflicting interpretation of 
others’ work. 
Therefore, this first systematic analysis of thirteen dKdm2 mutant alleles will be 
critical in resolving the role of this lysine demethylase in chromatin structure.  This work 
establishes Drosophila as a premier model for studying dKDM2 function because it can 
fuse genetic, developmental, cytological, and biochemical approaches.  The discoveries 
detailed in this work will be a fundamental resource for any subsequent work using these 
alleles in the future. 
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